Didn't find what you were looking for?

Feel free to reach out to us.

+91
Or reach us directly
Chat With Us
×

Dr. Navile Aditya Murali

Dr. Navile Aditya Murali

Dr. Navile Aditya Murali

QualificationMBBS, MD Internal Medicine, DM Medical Oncology, ECMO, DNB Medical Oncology, MRCP SCE UK

Experience16 years
Book an Appointment

Introduction

Dr. N.Aditya Murali is a Medical and Hemato-Oncologist with 16 years of clinical experience in the management of solid tumors and hematological malignancies. Dr. Murali brings an illustrious academic pedigree, comprising an MD in Internal Medicine, a DM in Medical Oncology, and a DNB in Medical Oncology, along with prestigious certifications of ECMO (ESMO) and MRCP SCE (UK). 

 

Before HCG, he was associated with various other reputable healthcare organizations, including Apollo Hospitals (Bangalore), Aster Hospitals (Bangalore), and Sarvodaya Hospital (Haryana), among others. Dr. Murali has also completed an observership in the Bone Marrow Transplant and Cellular Therapy Unit at Memorial Sloan Kettering Cancer Center, New York, further strengthening his expertise in transplant oncology and cellular therapies. 

Area of Expertise

·         Dr. Navile Aditya Murali is an accomplished Medical and Hemato-Oncologist in Bangalore and has over 16 years of experience in administering systemic therapies for different types of solid tumors and blood cancers. He is available for consultations at HCG Cancer Hospital, Bangalore.

·         He is also well-versed in treating blood malignancies using comprehensive bone marrow transplant programs.

·         His primary interest lies in the following areas:

Ø  Lung cancer management

Ø  Hematological malignancies, including leukemia, lymphoma, and multiple myeloma

Ø  Bone Marrow Transplantation

Ø  High-dose chemotherapy and autologous transplantation

Ø  Management of chemotherapy-related complications including MDR infections

Ø  Immunotherapy and cellular therapies

Research & Publications

·         Increasing incidence of multidrug-resistant Gram-negative septicaemia during induction therapy of acute myeloid leukaemia. Journal of Hospital Infection, Volume 93, Issue 3, 314 – 315.

·         Outcomes in Lung Cancer: 9-Year Experience From a Tertiary Cancer Center in India. J Glob Oncol. 2017 Jan 11;3(5):459-468.

·         Inadvertent intramuscular administration of vincristine in two pediatric patients with uneventful outcomes. Indian J Cancer 2016;53:303.

Awards & Accolades

Academic Contributions

 

·         Poster presentation at 16th World Lung Cancer Congress 2015, Denver, USA

·         Poster presentation at HEMATOCON 2015, Bangalore

·         Poster presentation at ESMO 2017, Madrid

·         Poster presentation at ACOS 2018, Thailand

·         Online publication at ASCO 2018, Chicago

 

Awards

 

·         Second Prize in Hematology Quiz at HEMATOCON 2015

·         National Finalist at TYSA 2016 – Best Young Outgoing Medical Oncology Fellow

Other Doctors

WhatsApp Icon